A core part of EMVC’s model is to develop a customized investment strategy for each company, so that the companies we work with have access to the right type of funding and support specific to their sector and stage of development. We achieve that by syndicating investment sources from the EMVC Evergreen EIS Fund, and network of investors from Family Offices, Wealth Managers, institutional VC investors and Corporate VC funds.
INVESTORS
REAL BUSINESSES, REAL INNOVATION, REAL VALUE
EMVC invest in B2B businesses built on core technological innovation, generating tangible economic value for the industrial sectors in the real economy.
STRONG CORPORATE LINKS
When Investing, we seek to leverage our network of corporate relationships both to validate the opportunities and to accelerate the growth of the Investee Companies.
FOLLOW ON CAPITAL AND CO-INVESTMENT
Our Portfolio companies benefit from access to follow-on funding, such as through EMVC’s contacts with institutional investors, corporate venturing teams and investment vehicles.
Selected Portfolio Companies
SECTORS OF INTEREST
ENERGY
Investing towards a significant positive contribution to the energy balance.
TRANSPORT
Technologies developing energy efficiency, autonomy, and monitoring in transport systems.
CIRCULAR ECONOMY
Supporting technologies designing circular industrial processes to tackle waste streams.
HEALTH TECH
Developing health benefits platforms, investing in innovation and research.
SMART CITY
Improving city assets and infrastructure using IoT and smart technologies.
INDUSTRIAL HIGH-TECH
Advancing the impact of robotics, IoT, and high-tech in industry.
FUNDING
We invest in and accelerate the growth of promising early-stage hardware companies with an innovative prototype. We invest in companies that are at a more advanced stage of development, and facilitate access to additional funding through our network.
LATEST NEWS
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES...
by EMV Capital Ltd
- Jun 10, 2021
NetScientific PLC – Result of Placing and Total Voting Rights
Jun 10, 2021
London, UK 2nd June 2021 (PR WEB) EMV Capital...
by Agnese Palermo
- Jun 02, 2021
Vortex Biosciences, liquid biopsy for cancer diagnosis, announces experienced start-up leader Dr. Adrian Kinkaid as new CEO
Jun 02, 2021
The funding will accelerate the rollout of its Smart...
- May 20, 2021
EMV Capital leads £3.4m investment in smart sensor maker PointGrab – helps businesses maintain social distance in post-COVID offices
May 20, 2021
Technology allows hospitals to expand operating theatre/ICU capacity quickly...
- May 13, 2021
EMV Capital closes £2.9m pre-series A round for anaesthetic gas recycling tech business SageTech Medical
May 13, 2021
Business is expected to benefit from the global rollout...
- Apr 28, 2021
5G and satellite phased array antenna designer Sofant Technologies raises £740k in oversubscribed funding round led by EMV Capital
Apr 28, 2021
Meet the Manager – Ilian Iliev – EMV Capital...
- Mar 11, 2021
Dr Ilian Iliev interview with Mark Brownidge – EIS Association
Mar 11, 2021
| Disclaimer
Investing in start-ups and early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution. Investments made in investee companies via funds managed by Sapphire Capital Partners LLP are not covered by the Financial Services Compensation Scheme (FSCS). For more details, please contact us or refer to their website: https://www.fscs.org.uk |